Cargando…
The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors
Given the upsurge of drug-resistant tuberculosis worldwide, there is much focus on developing novel drug combinations allowing shorter treatment duration and a lower toxicity profile. Nicotinamide adenine dinucleotide (NAD) biosynthesis targeting is acknowledged as a promising strategy to combat dru...
Autores principales: | Rohde, Kyle H., Sorci, Leonardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873932/ https://www.ncbi.nlm.nih.gov/pubmed/33584600 http://dx.doi.org/10.3389/fmicb.2020.634640 |
Ejemplares similares
-
How Does Fusarium oxysporum Sense and Respond to Nicotinaldehyde, an Inhibitor of the NAD(+) Salvage Biosynthesis Pathway?
por: Anand, Gautam, et al.
Publicado: (2019) -
Early Drug Development and Evaluation of Putative Antitubercular Compounds in the -Omics Era
por: Minias, Alina, et al.
Publicado: (2021) -
Enzymology of extracellular NAD metabolism
por: Gasparrini, Massimiliano, et al.
Publicado: (2021) -
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug
por: Mori, Giorgia, et al.
Publicado: (2020) -
Erythema multiforme due to antitubercular drugs
por: Gulati, Sameer, et al.
Publicado: (2011)